AG˹ٷ

STOCK TITAN

[Form 4] Steelcase, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.

Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (�0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.

VirnetX Holding Corp. (VHC) ha presentato un modulo Form 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali relativi a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione è esclusivamente per il saldo fiscale e non riguarda una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e a 11.278 azioni indirette detenute tramite The Short Revocable Living Trust, mantenendo sostanzialmente invariata l’esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti strumenti derivati, né sono state comunicate altre attività da parte degli insider. Considerata la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa dell’operazione, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional por parte del Científico Principal Robert D. Short III el 07/07/2025. La empresa retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionadas con premios de acciones restringidas otorgados previamente. La nota explicativa confirma que la transacción es exclusivamente para el pago de impuestos y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y 11,278 acciones indirectas mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short esencialmente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, y no se divulgó ninguna otra actividad de los insiders. Dado el tamaño insignificante (�0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene significado limitado para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)� 2025� 7� 7� 최고 과학� Robert D. Short III� 자동적이� 비재량적� 내부� 거래� 보고하는 Form 4� 제출했습니다. 회사� 이전� 부여된 제한 주식 보상� 관련된 급여 � 소득� 의무� 충족하기 위해 50 보통�(거래 코드 F)� 주당 $12.34� 원천징수했습니다. 설명 노트� � 거래가 오직 세금 정산� 위한 것이� 시장 공개 판매와� 무관�� 확인합니�.

거래 � 소유권은 31,848 직접 주식� The Short Revocable Living Trust� 통해 보유� 11,278 간접 주식으로, Short� 전체 경제� 노출은 사실� 변함이 없습니다. 파생 증권� 행사, 취득 또는 처분은 없었�, 다른 내부� 활동� 공개되지 않았습니�. 거래 규모가 미미(� Short � 보유량의 0.1%)하고 행정� 성격임을 고려� �, 이번 제출은 투자� 미치� 영향� 제한�이며 VirnetX� 대� 내부자들� 심리 변화도 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 signalant une transaction automatique et non discrétionnaire d’initié par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement le règlement fiscal et n’implique pas une vente sur le marché ouvert.

Après la transaction, la détention s’élève à 31 848 actions directes et 11 278 actions indirectes détenues via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Étant donné la taille négligeable (�0,1 % du total des avoirs de Short) et la nature administrative, ce dépôt a une signification limitée pour les investisseurs et ne signale aucun changement de sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die Erläuterung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien sowie 11.278 indirekte Aktien über The Short Revocable Living Trust, wodurch seine gesamte wirtschaftliche Beteiligung im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unerheblichen Größe (�0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Only 50 shares withheld for taxes; negligible impact and neutral signal.

The Code F designation reveals an automatic share surrender to cover tax obligations on vested stock, a routine event that does not reflect a discretionary buy or sell decision. Post-withholding, the insider still controls roughly 43 k shares, indicating sustained alignment with shareholders. Because the transaction involves less than 1 % of his position and no derivatives, liquidity or valuation impact is essentially nil. From a governance and sentiment perspective, the filing is neutral; it neither strengthens nor weakens the investment case for VHC.

VirnetX Holding Corp. (VHC) ha presentato un modulo Form 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali relativi a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione è esclusivamente per il saldo fiscale e non riguarda una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e a 11.278 azioni indirette detenute tramite The Short Revocable Living Trust, mantenendo sostanzialmente invariata l’esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti strumenti derivati, né sono state comunicate altre attività da parte degli insider. Considerata la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa dell’operazione, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional por parte del Científico Principal Robert D. Short III el 07/07/2025. La empresa retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionadas con premios de acciones restringidas otorgados previamente. La nota explicativa confirma que la transacción es exclusivamente para el pago de impuestos y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y 11,278 acciones indirectas mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short esencialmente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, y no se divulgó ninguna otra actividad de los insiders. Dado el tamaño insignificante (�0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene significado limitado para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)� 2025� 7� 7� 최고 과학� Robert D. Short III� 자동적이� 비재량적� 내부� 거래� 보고하는 Form 4� 제출했습니다. 회사� 이전� 부여된 제한 주식 보상� 관련된 급여 � 소득� 의무� 충족하기 위해 50 보통�(거래 코드 F)� 주당 $12.34� 원천징수했습니다. 설명 노트� � 거래가 오직 세금 정산� 위한 것이� 시장 공개 판매와� 무관�� 확인합니�.

거래 � 소유권은 31,848 직접 주식� The Short Revocable Living Trust� 통해 보유� 11,278 간접 주식으로, Short� 전체 경제� 노출은 사실� 변함이 없습니다. 파생 증권� 행사, 취득 또는 처분은 없었�, 다른 내부� 활동� 공개되지 않았습니�. 거래 규모가 미미(� Short � 보유량의 0.1%)하고 행정� 성격임을 고려� �, 이번 제출은 투자� 미치� 영향� 제한�이며 VirnetX� 대� 내부자들� 심리 변화도 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 signalant une transaction automatique et non discrétionnaire d’initié par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement le règlement fiscal et n’implique pas une vente sur le marché ouvert.

Après la transaction, la détention s’élève à 31 848 actions directes et 11 278 actions indirectes détenues via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Étant donné la taille négligeable (�0,1 % du total des avoirs de Short) et la nature administrative, ce dépôt a une signification limitée pour les investisseurs et ne signale aucun changement de sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die Erläuterung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien sowie 11.278 indirekte Aktien über The Short Revocable Living Trust, wodurch seine gesamte wirtschaftliche Beteiligung im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unerheblichen Größe (�0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krestakos Robert G

(Last) (First) (Middle)
STEELCASE INC.
901 44TH ST SE

(Street)
GRAND RAPIDS MI 49508

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STEELCASE INC [ NYSE: SCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Operations Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/11/2025 S 12,000 D $10.6288(1) 127,912 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.67, inclusive. The reporting person undertakes to provide to Steelcase Inc., any security holder of Steelcase Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
Liesl A. Maloney, by power of attorney 07/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did VirnetX (VHC) disclose in the latest Form 4?

The company reported that Chief Scientist Robert D. Short III had 50 shares withheld on 07/07/2025 to cover tax obligations.

Was the 50-share transaction an open-market sale of VHC stock?

No. The shares were automatically withheld by VirnetX for taxes (Transaction Code F), not sold on the open market.

How many VirnetX shares does Robert D. Short III hold after the transaction?

He owns 31,848 shares directly and 11,278 shares indirectly via The Short Revocable Living Trust.

Did the filing report any derivative securities activity?

No derivative securities were acquired, exercised, or disposed of in this Form 4.

What is the investment significance of this Form 4 for VHC shareholders?

The filing is largely administrative; the small tax-withholding action does not indicate a change in insider sentiment or company outlook.
Steelcase

NYSE:SCS

SCS Rankings

SCS Latest News

SCS Latest SEC Filings

SCS Stock Data

1.18B
83.36M
12.91%
97.07%
1.69%
Furnishings, Fixtures & Appliances
Office Furniture (no Wood)
United States
GRAND RAPIDS